Arbutus Biopharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '25 Jan 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	605	495	329	303	389	221	Upgrade
Market Cap Growth	-6.38%	50.38%	8.78%	-22.14%	76.02%	69.34%	Upgrade
Enterprise Value	535	396	223	157	411	258	Upgrade
Last Close Price	2.67	2.61	1.96	1.92	2.95	-	Upgrade
PS Ratio	53.72	100.41	23.11	9.34	47.89	43.60	Upgrade
PB Ratio	9.98	6.36	3.95	2.66	3.11	2.96	Upgrade
P/TBV Ratio	9.98	6.36	3.95	2.66	3.11	-	Upgrade
EV/Sales Ratio	46.81	80.32	15.69	4.85	50.59	51.00	Upgrade
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22	Upgrade
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06	Upgrade
Quick Ratio	19.76	8.03	5.71	4.51	13.92	13.06	Upgrade
Current Ratio	20.53	8.15	5.87	4.60	14.32	13.39	Upgrade
Return on Equity (ROE)	-52.82%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%	Upgrade
Return on Assets (ROA)	-21.01%	-33.36%	-28.70%	-19.76%	-26.22%	-29.51%	Upgrade
Return on Capital (ROIC)	-25.39%	-42.21%	-36.93%	-23.40%	-28.63%	-32.60%	Upgrade
Earnings Yield	-6.55%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%	Upgrade
FCF Yield	-7.28%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%	Upgrade
Buyback Yield / Dilution	-8.74%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.